Home › NDC Lookup › RxCUI directory › RxCUI 2677909

Resmetirom 60 MG Oral Tablet [Rezdiffra] — RxCUI 2677909

Name: Resmetirom 60 MG Oral Tablet [Rezdiffra] (RxCUI 2677909)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2677909 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2677909

Official nameResmetirom 60 MG Oral Tablet [Rezdiffra]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asRezdiffra 60 MG Oral Tablet

FDA products mapped3

Package NDCs mapped5

Reported Medicaid activity (SDUD)23,248 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Resmetirom 60 MG Oral Tablet [Rezdiffra] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Resmetirom 60 MG Oral Tablet [Rezdiffra] RxCUI 2677909 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Resmetirom 2677894 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Rezdiffra 2677900 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Resmetirom Oral Tablet 2677898 SCDF
- Resmetirom Oral Product 2677896 SCDG
- Resmetirom Pill 2677897 SCDG
- Resmetirom Oral Tablet [Rezdiffra] 2677904 SBDF
- Rezdiffra Oral Product 2677902 SBDG
- Rezdiffra Pill 2677903 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Resmetirom 60 MG Oral Tablet 2677907 SCD
- Resmetirom 60 MG 2677906 SCDC
- Resmetirom 60 MG [Rezdiffra] 2677908 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Resmetirom 60 MG Oral Tablet SCD · 2677907
Resmetirom 60 MG SCDC · 2677906
Resmetirom Oral Tablet SCDF · 2677898
Resmetirom Oral Product SCDG · 2677896
Resmetirom Pill SCDG · 2677897

Brand-Name Concepts

Resmetirom 60 MG [Rezdiffra] SBDC · 2677908
Resmetirom Oral Tablet [Rezdiffra] SBDF · 2677904
Rezdiffra Oral Product SBDG · 2677902
Rezdiffra Pill SBDG · 2677903
Rezdiffra BN · 2677900

📦 FDA Products & Package NDCs

3 products · 5 package NDCs

5 package NDCs map to RxCUI 2677909 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
82576-0060-30	30 TABLET, COATED in 1 BOTTLE (82576-060-30)	REZDIFFRA	Madrigal Pharmaceuticals, Inc.	2024-03-14
82576-0080-30	30 TABLET, COATED in 1 BOTTLE (82576-080-30)	REZDIFFRA	Madrigal Pharmaceuticals, Inc.	2024-03-14
82576-0080-90	90 TABLET, COATED in 1 BOTTLE (82576-080-90)	REZDIFFRA	Madrigal Pharmaceuticals, Inc.	2024-03-14
82576-0100-30	30 TABLET, COATED in 1 BOTTLE (82576-100-30)	REZDIFFRA	Madrigal Pharmaceuticals, Inc.	2024-03-14
82576-0100-90	90 TABLET, COATED in 1 BOTTLE (82576-100-90)	REZDIFFRA	Madrigal Pharmaceuticals, Inc.	2024-03-14

Observed labelers: Madrigal Pharmaceuticals, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.